Back to Newsroom
Back to Newsroom

Dry Eye Disease Treatment Market to Exceed US$ 8.7 Bn by 2030; TMR Study

Tuesday, 11 October 2022 04:33 AM

WILMINGTON, DE / ACCESSWIRE / October 11, 2022 / Transparency Market Research Inc. - Widespread uptake of anti-inflammatory products and medications for artificial tears has boosted the dry eye disease treatment market business prospects. Focus on evidence-based as well personalized treatments has led stakeholders to adopt step therapy approaches to dry eye disease management, which underpins vast lucrative avenue that is being pursued by many stakeholders. The global dry eye disease treatment market is projected to surpass worth of US$ 8.7 Bn by 2030.

Transparency Market Research inc., Tuesday, October 11, 2022, Press release picture

Commercialization of devices based on intense pulsed light technology hinged on the patient acceptance of those for effectively reducing inflammation. The massive adoption of medical devices is generating sizable revenue opportunities for players in the dry eye disease treatment market. Medtech companies are keen on unveiling cutting-edge technology to improve long-term patient outcomes, indicate major dry eye disease treatment market growth factors. Targeting of inflammatory dry eye pathways evokes considerable attention among industry players, and in the near future will open up new avenues.

Get Exclusive PDF Sample Copy of Dry Eye Disease Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77640

Key Findings of Dry Eye Disease Treatment Market Study

  • Growing Acceptance of Devices Based on Intense Pulsed Light Technology Steering Lucrative Opportunities: Rising demand for intense pulsed light technology in Europe will spur revenue streams in the global dry eye disease treatment market. The unmet need for more effective anti-inflammatory products will open up new revenue streams, opines the market analysts.

Novel contact lens continues to attract massive attention among patients for the management of dry eye disease treatment. Thus, innovations in contact lens will extend horizon in inflammatory dry eye disease treatment.

  • Step Therapy Approaches for Dry Eye Disease Management Enrich Market Prospects: Rise in demand for multistage management algorithms has opened up promising avenues for companies in dry eye disease treatment market. Players are keen on offering a range of interventions for the management of the disease notably that provide relief to the key ocular symptoms. This will enable them to augment their dry eye disease treatment market shares.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=77640

Dry Eye Disease Treatment Market: Drivers

  • Prevalence of dry eye diseases worldwide is a key driver of the market. Especially in developed world, with U.S. being a notable example, the public health burden of the disease has been considerable.
  • A rapidly aging population in several developing and some developed regions is a key driver of the dry eye disease treatment market.
  • Advancements made in contact lens therapeutics, prescription drugs, and medical devices used in the management of dry eye disease treatment are catalyzing the strides of the market.

Dry Eye Disease Treatment Market: Regional Growth Dynamics

  • North America is anticipated to hold a major share of the global dry eye disease treatment market during the forecast period. A spate of product approvals over the past few years and rapid strides made in lab infrastructure have reinforced revenue streams for firms in the regional market.
  • Asia Pacific is a remarkably lucrative market. The growth of revenues is fueled by rapidly growing patient pool, especially of elderly patients, and spending made by governments to strengthen the healthcare sector notably in developing regions.

Dry Eye Disease Treatment Market: Competition Landscape

Top players are geared toward unveiling innovative products to bolster their position in dry eye disease treatment market. To this end, many of the companies have entered into collaborations.

Some of the key players are RegeneRx (ReGenTree, LLC), Sentiss Pharma Pvt. Ltd., Otsuka Pharmaceutical Co., Ltd., Novartis AG, Johnson & Johnson, OASIS Medical, and Allergan.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77640

Dry Eye Disease Treatment Market Segmentation

Global Dry Eye Disease Treatment Market: Segmentation:

Product

Artificial Tears

Anti-inflammatory

  • Cyclosporine
  • Corticosteroid
  • Others

Punctal Plugs

Secretagogue

Others

Disease

  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome

Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Homeopathic Products Market: The global homeopathic products market is anticipated to reach more than US$ 32.4 Bn by the end of 2031 at a CAGR of 11.6% from 2022 to 2031.

Pain Management Therapeutics Market: The global pain management therapeutics market is anticipated to reach more than US$ 98.0 Bn by the end of 2031 at a CAGR of 2.9% from 2022 to 2031.

Peptide Therapeutics Market: The global peptide therapeutics market is anticipated to reach more than US$ 91.25 Bn by 2031 at a CAGR of 8.8% from 2022 to 2031.

Collagen Peptide & Gelatin Market: The global collagen peptide and gelatin market is anticipated to reach more than US$ 7.8 Bn by the end of 2031 at a CAGR of 5.0% from 2022 to 2031.

Premenstrual Syndrome Treatment Market: The global premenstrual syndrome treatment market is anticipated to reach more than US$ 1.9 Bn by the end of 2031 at a CAGR of 3.4% from 2022 to 2031.

Synthetic Biology Market: The global synthetic biology market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 at a CAGR of 21.3% from 2022 to 2031.

Dyspareunia Treatment Market: The global dyspareunia treatment market is anticipated to reach more than US$ 1.02 Bn by the end of 2031 at a CAGR of 4.1% from 2022 to 2031.

Surgical Retractors Market: The global surgical retractors market is expected to expand at a CAGR of ~5% during the forecast period 2020 - 2030.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]

SOURCE: Transparency Market Research Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: